mock ppt new 1
TRANSCRIPT
-
7/31/2019 Mock Ppt New 1
1/31
INTRODUCTION
-
7/31/2019 Mock Ppt New 1
2/31
According to the research conducted on Menopause in 1990s,the WHO defined
menopause as a time of a womans life when reproductive capacity ceases. The
ovaries stop functioning and their production of steroid and peptide hormones falls.
Dharwad, Vaidya et.al further elaborated that it is a phase when she no longer
experiences menstruation, technically her body begins to produce less and less
progesterone and estrogen and eventually her periods cease. Menopause typically
occurs in a womans late 40s to early 50s.
The rise in heart rate during exercise is considered to be due to the combination
of parasympathetic withdrawal and sympathetic activation whereas the fall in
heart rate immediately after exercise is considered to be a function of
reactivation of parasympathetic nervous system.
-
7/31/2019 Mock Ppt New 1
3/31
Christopher R.Col stated that a delayed decrease in the heart rate
during the first minute after graded exercise, which may be areflection of decreased vagal activity, is a powerful predictor of
overall mortality.
However, Eugene H.Blackstone emphasised on the fact that the
heart rate recovery after submaximal exercise was a powerful
predictor of mortality in a population based cohort of adults
without clinically evident cardiovascular disease.
Very few studies have been conducted to study these importantautonomic system parameters in elderly women after
submaximal exercise effort as menopause approaches.
-
7/31/2019 Mock Ppt New 1
4/31
AIMS AND OBJECTIVES
To study the effect of menopause on Rate pressure product,
Heart rate recovery, and peak expiratory flow rates in women
with sub-maximal exercise testing.
-
7/31/2019 Mock Ppt New 1
5/31
STATEMENT OF QUESTION
Does menopause have any effect on cardiopulmonary
parameters in women ?
-
7/31/2019 Mock Ppt New 1
6/31
HYPOTHESIS
H1:
There is a significant effect of menopause on rate pressure
product, heart rate recovery, and peak expiratory flow rate in
women subjected to sub-maximal exercise testing.
H0:
There is no significant effect of menopause on rate pressure
product, heart rate recovery, and peak expiratory flow rates in
women subjected to sub-maximal exercise testing.
-
7/31/2019 Mock Ppt New 1
7/31
METHODOLOGY
-
7/31/2019 Mock Ppt New 1
8/31
STUDY DESIGN:
Observational
SAMPLE SIZE: Total 60 subjects divided in 2 groups :
Group A 30 non menopausal women
Group B 30 post-menopausal women
-
7/31/2019 Mock Ppt New 1
9/31
INCLUSION CRITERIA:
Women of age group 40-607.
Women with no menstrual
periods for 12 consecutive
months.
Normal BMI8.
EXCLUSION CRITERIA:
Smokers9
Uncontrolled Diabetics8
Uncontrolled Hypertensive8
Cancer patients8
Recent post-operative cases8
Women on HRT
10
Osteoporosis10
Hysterectomy10
Peri-menopausal women
-
7/31/2019 Mock Ppt New 1
10/31
OUTCOME MEASURES
Rate Pressure Product (R.P.P)
Distance covered on 6MWT (6MWD)
Peak expiratory flow rate (PEFR)
Heart rate recovery(HRR)
-
7/31/2019 Mock Ppt New 1
11/31
INSTRUMENTATION :
Wrights Peak flow meter
Stethoscope
Sphygmomanometer
Actitrainer solution-Polar Wearlink heart monitor
strap
Stop-watch.
-
7/31/2019 Mock Ppt New 1
12/31
PROTOCOL/PROCEDURE
-
7/31/2019 Mock Ppt New 1
13/31
60 women as per inclusion criteria were recruited for the study
Purpose of study was explained to the subject
Informed consent was taken
The subjects were divided in two groups according to the
gynaecological history
__________________________________________
Group A Group B
(non-menopausal women) ( Post menopausal women)
N=30 N=30
-
7/31/2019 Mock Ppt New 1
14/31
The subject was allowed to be seated at rest in a chair for at least 10
min before the test was started. Pre-assessment of the subjects was
done and the Heart rate , Respiratory rate, Blood pressure and PEFR
were noted.
A 6MWT was conducted according to the ATS Guidelines and post
sub-maximal exercise parameters in terms of H.R, B.P, R.R,
RPE,6MWD and PEFR was noted.
Immediately after exercise the subject was made to sit on a chair and
heart rate recovery data was obtained at 1 min, 2 min and if required
at 3 min.
-
7/31/2019 Mock Ppt New 1
15/31
Instruments used in the research study
-
7/31/2019 Mock Ppt New 1
16/31
Subject performing PFT
-
7/31/2019 Mock Ppt New 1
17/31
RESULTS
-
7/31/2019 Mock Ppt New 1
18/31
Variable Non menopausal Post menopausal
Number 30 30
Age (years) 44.33 2.06 54.53 2.92
Weight (kg) 62.07 3.68 59.8 4.54
Height (cm) 159.4 4.05 158.03 4.8
BMI (kg/m2) 24.42 .9849 23.97 1.62
Resting SBP (mmHg) 119.27 8.03 121.5 9.48
Resting DBP (mmHg) 76.93 5.27 78.96 5.68
RPP at rest 8.51 .83 8.64 .92
PEFR at rest ( ) 4.93 1.25 4.85 1.37
Table 1: Physical and cardiopulmonary parameters of the subjects studied
-
7/31/2019 Mock Ppt New 1
19/31
RPP *
1000
Mean + SD t P value
Group A Group B
Pre test
8.51
.8328
12.52
1.02
-.822 .477
Post test
8.64
.9235
12.75
1.12
-.948 .265
Table 2: Result of the mean& the t-test of Rate Pressure Product of both
the Groups on 6 MWT
0
2
4
6
8
10
12
14
Pre test Post Test
RPP*1000
Group A
Group B
Graph 1: Result comparing the mean ofRate Pressure Product of both Group
on 6MWT
-
7/31/2019 Mock Ppt New 1
20/31
PEFR
(l/mint)
Mean + SD t P value
Group A Group B
Pre test 5.76 +
1.42
5.68 +
1.51
.20 .660
Post test 4.84 + 1.2 4.82 +
1.37
.169 .586
Table 3: Comparing the mean&Result of the t-test of PEFR of bothGroup after 6 MWT
0
2
4
6
8
10
12
14
Pre test Post Test
PEFR
Group A
Group B
Graph 2: Result comparing the
mean of PEFR of both Group On 6MWT
-
7/31/2019 Mock Ppt New 1
21/31
Variabl
e
Mean + SD t P value
Group A Group B
6MWD 564.33
+ 40.23
538.33
+ 45.8
2.336 .023
RPE*
4.833*
+ .36
4.5* +
.4
.339 .736
HRR 29 + 2.8
29.1 +
3.87
-.190 .850
Table 4: Comparing the mean& the result of the t-test of
cardiopulmonary variables postsix-minute walk
56.433
4.833
29
53.833
4.5
29.1
6MWD*10 (mts)
RPE *
HRR
POST TEST
Group B Group A
Graph 3: Comparing the mean post test
cardio pulmonary variables on 6MWT
-
7/31/2019 Mock Ppt New 1
22/31
The results reveals a significant difference in betweengroups in the 6 minute walk distance (P< 0.05). Thenon menopausal women covered a significantly greater
mean distance of 564.33 + 42.23 than the postmenopausal women who covered a mean distance of538.33 + 45.8 in comparison.
-
7/31/2019 Mock Ppt New 1
23/31
DISCUSSION
-
7/31/2019 Mock Ppt New 1
24/31
At menopause, hormone levels do not always decline uniformly,but fluctuate. With an advancement in chronological stage the
visible signs of aging begin to appear. In the last years, the 6MWT has become one of the most
popular clinical exercise test for evaluating functional capacity.The test has close similarities to activities of daily living and canbe performed by many elderly, frail, and severely limitedpatients who could not be evaluated by standard maximalsymptom-limited exercise tests, as are cardiac patients afterrecent major surgery.
One of the primary measures of this test is 6-min walk distance,
but during the 6MWT data can also be collected about thepatients blood oxygen saturation and perception ofdyspneaduring exertion. The 6MWT can also be used to measurefunctional status and for epidemiologic purposes.
-
7/31/2019 Mock Ppt New 1
25/31
There was also a strong association between decreasingexercise capacity and an abnormal value for heart raterecovery in both men and women. A reduction in the heartrate of 12 beats per minute after the cessation of exercise wasused as the definition of a low value for the recovery of theheart rate.
As studied by Christopher R.Cole et.al, a low value for heart-
rate recovery after exercise testing, which has been previouslyshown to be a marker of decreased vagal activity, was found tobe a powerful and independent predictor of the risk of death.
The mean HRR in the first minute in both non and post-menopausal groups in our study was 29 + 2.82 and 29.16 + 3.87
respectively. However no significant difference was found inbetween the non and post menopausal women aftersubmaximal exercise testing.
-
7/31/2019 Mock Ppt New 1
26/31
The results of our study demonstrates a significantdecrease in the distance walked on sub-maximal
exercise testing, which support the studies that suggestthat menopause effects the exercise capacity of women.
The 6MWD of healthy subjects range from 400 to 700m.The mean distance covered by both the groups in ourstudy falls in this range i.e. the non-menopausal womencovered a significantly greater mean distance of 564.33+42.23 than the post-menopausal women who covered amean distance of 538.33+ 45.8 in comparison.
Magdalena et.al conducted a study on pre and post-
menopausal women indicating that BMI,if not withinnormal limits i.e overweight (obesity), is a risk factor forhealth.
-
7/31/2019 Mock Ppt New 1
27/31
In the present study, BMI was within the normallimits, where the baseline variables in both the groupsdid not show any significant difference.
The study can be further extended on the assessmentand comparison of the cardiovascular parameters onsubmaximal exercise testing in post menopausalwomen with BMI within normal limits and overweightcategories.
-
7/31/2019 Mock Ppt New 1
28/31
The study conducted by Medical research Society in2001 very well supports the above where it has beenobserved that , in post-menopausal women, muscleperformance, muscle mass and muscle compositionare improved by HRT and also that the beneficialeffects of HRT combined with high-impact physicaltraining may exceed those of HRT alone.
It is also well known that menopause is accompaniedby an increased incidence of cardiovascular diseaseand changes in bone metabolism, and that hormonereplacement therapy (HRT) has potential benefits inreducing cardiovascular risk and bone loss .
-
7/31/2019 Mock Ppt New 1
29/31
CONCLUSION
-
7/31/2019 Mock Ppt New 1
30/31
There is no significant effect of early menopause onrate pressure product, heart rate recovery, and peakexpiratory flow rates in elderly women subjected to
sub-maximal exercise testing. However, the results ofour study demonstrates a significant decrease in thedistance walked on sub-maximal exercise testing inthe women of early menopause.
-
7/31/2019 Mock Ppt New 1
31/31
THANK YOU!!!